Tag: pain (pain management)

Rapid Relief of Opioid-Induced Constipation With MNTX

Subcutaneously administered methylnaltrexone (MNTX) (Relistor), a peripherally acting µ-opioid receptor antagonist, relieves opioid-induced constipation (OID) in both chronic, noncancer-related illness and cancer-related illness, a new...

Rilonacept Resolves, Prevents Pericarditis Recurrence

Results of a phase 3 trial show that treatment with rilonacept (Arcalyst), a drug already approved to treat inflammatory disease, both resolved acute episodes of...

New Risks of Prescription Opioids Discovered

Prescription opioid use increases the risk for major depressive disorder (MDD) and anxiety and stress-related disorders (ASRD), new genetic evidence shows. The findings also suggest...

Painful Ethical Choices in 2020 vs 2010: How Has Thinking Changed?

Much has changed in the 10 years since Medscape’s first survey on what physicians would do when faced with painful choices in patient care. A...

SAMSON Pins Most Muscle Pain With Statins on the Nocebo Effect

A novel randomized trial taking on a vexing issue around one of the world’s most commonly prescribed medications has concluded that frequently intolerable statin side...

Time to Discuss the Unpleasant Side Effects of COVID Shots?

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. A health worker injects a woman during clinical trials for a...

Sleep Apnea Found to Impact Pain Severity in Younger Adults

Sleep specialists might want to take a closer look at the connections between obstructive sleep apnea, chronic pain, and reported pain intensity in younger patients....

JIA Arthritis and Uveitis Flares ‘Often Run Parallel’

Children with juvenile idiopathic arthritis–associated uveitis (JIA-U) are significantly more likely to experience a flare in their eye disease if their arthritis is also worsening,...

The Ally in the Waiting Room

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. We think of a patient’s recovery happening in multiple locations –...

Relugolix Combo Effective for Uterine Fibroids Through 1 Year

A combination therapy using the experimental drug relugolix was effective in treating pain and heavy bleeding from uterine fibroids for a full year, according to...

Pandemic Stress Takes Its Toll

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center.   In late March, shortly after New York state closed nonessential...

Late-Stage Lyme Disease and Psychiatric Illness: Final Verdict?

Lyme neuroborreliosis (LN), a late-stage manifestation of Lyme disease, is not associated with an increased risk of developing serious psychiatric illness, results of a large,...

FDA Issues New NSAIDs Warning for Second Half of Pregnancy

The US Food and Drug Administration released new warnings today that most nonsteroidal anti-inflammatory agents (NSAIDs) carry an elevated risk for kidney complications in an...

Positive Topline Results for New Cervical Dystonia Treatment

DaxibotulinumtoxinA for Injection for treatment for cervical dystonia met the primary and all secondary endpoints in the phase 3 ASPEN-1 study, according to topline results...

Pain Pill Abuse Higher in Adolescent CBD Oil Users

Adolescent users of cannabidiol (CBD) oil are far more likely to engage in risk-taking behaviors ― such as illegally taking prescription pain medications ― than...

Weight Loss in Obesity May Stall Neuropathy Progress

Among obese people with polyneuropathy, significant weight loss appears to halt progression of the painful condition while improving some key measures, a new study suggests....

‘Overwhelming Evidence’ FDA’s Opioid Approval Process Is Shoddy

Despite the ongoing epidemic of misuse, overuse, and diversion of opioids, the US Food and Drug Administration (FDA) has set a low bar for approval...

Tough to Tell COVID From Smoke Inhalation Symptoms

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. The patients walk into Dr. Melissa Marshall’s community clinics in Northern...

Reworked OxyContin Fails to Cut Overall Abuse, FDA Panel Says

The long-awaited post-marketing studies of the abuse-deterrent formulation (ADF) of OxyContin (Perdue Pharma L.P.) received mixed reviews from a US Food and Drug Administration (FDA)...

Multiple Sclerosis Prodrome Holds Promise of Earlier Diagnosis

“It is time that the prodromal phase of multiple sclerosis is formally recognized.” That was the conclusion of Helen Tremlett, PhD, delivering the opening plenary...

Hazardous Air Pollutants Make COVID-19 More Serious

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. This article was produced in partnership with The Times-Picayune and The...

The Long Road to a PsA Prevention Trial

About one-third of all patients with psoriasis will develop psoriatic arthritis (PsA), a condition that comes with a host of vague symptoms and no definitive...

Resident Who Sent Anti-Semitic Tweets Barred From Medicine

A first-year resident who was fired in 2018 from the Cleveland Clinic in Ohio after her anti-Semitic tweets were discovered has now permanently lost her...

When Viruses Collide: Flu Season During Pandemic

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. The medical community is about to find out how prepared it...

Some COVID-19 Symptoms Last for Months, Study Finds

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. A British study says many coronavirus patients suffer symptoms such as...